You may want to take a fresh look at business opportunities and investments in India, if a new World Bank report is to be believed. In November 2001, Goldman Sachs published a landmark paper where they identified India, along with Brazil, China, and Russia as the four “BRIC” economies that...
2015: Highest M&A Deals in India Healthcare Market
According to a report in Live Mint which quoted data from VCCEdge, outbound mergers and acquisitions in the healthcare sector in India were worth $1.5 billion in 2015 as against $251 million in 2014. Outbound Acquisitions Acquirer Acquiree Deal Size Lupin, India Gavis Pharmaceuticals, U.S. $880 million Cipla, India InvaGen...
Mylan To Invest an Additional $5 billion in India
The Nasdaq traded generics pharmaceutical company Mylan said it was keen to expand its presence in the southern state of Andhra Pradesh with an additional investment of $5 billion. Rajeev Mukundan, senior vice-president (legal), Mylan, who was part of a delegation representing the US-India Business Council, informed Chandrababu Naidu, the...
Mylan buys two pharma factories
Mylan Inc, a pharmaceuticals company headquartered in Cecil Township, Pennsylvania completed a $26 million buyout of a new formulation facility in Madhya Pradesh that it picked up from India's Unichem Laboratories. Mylan also closed on a $32.5 million deal to buy a nearly new, FDA-approved plant in India from SMS...
Mylan buys Indian production unit from SMS Pharma for $33 million
India’s SMS Pharmaceuticals confirmed that it has sold its manufacturing units in Visakhapatnam, Andhra Pradesh, to U.S. generic drugmaker Mylan Laboratories for $33 million. The unit is makes bulk drugs and formulations for cancer treatment. The deal is the second Indian acquisition by Mylan after it acquired 71.5 % of ...